May 3, 2015

AIT Granted EU ODD for NO for the Treatment of CF

Advanced Inhalation Therap …

Read more

April 21, 2015

AIT to present AIT-RSV at Medical Meetings

Advanced Inhalation Therap …

Read more

February 22, 2015

AIT Recieves ODD for Adjunctive Treatment of CF

Advanced Inhalation Therap …

Read more

February 10, 2014

Phase II Clinical Trial For Cystic Fibrosis

AIT’s Phase II Clinical Trial for Cystic Fibrosis Adds Schneider Children’s Medical Center of Israel as Second Site in Expanded Trial Study Aims To Evaluate Improvement in Lung Function after Treatment with NOxCureCF

Read more

February 3, 2014

AIT To Present NOxCureBR

AIT To Present NOxCureBR at the Annual Meeting of the Israeli Association of Clinical Pediatrics (Israeli clinical Pediatric Society 2014)

Read more

January 23, 2014

AIT To Present Phase II Clinical Data For NOxCureBR

AIT To Present Phase II Clinical Data for NOxCureBR, A Treatment for Acute Bronchiolitis and RSV in infants

Read more

January 7, 2014

AIT Announces Phase II Study Of NOxCureCF

AIT Announces Phase II Study of NOxCureCF, a Respiratory Treatment for Cystic Fibrosis Patients Using a Nitric Oxide-Base Formulation Enrollment in the Multicenter Trial Begins in Soroka Medical Center in Israel

Read more

December 16, 2013

Hannah Blau, M.B.B.S, Joins AIT’s Scientific Advisory Board

Rehovot, Israel – 16 December 2013 – Advanced Inhalation Therapies (AIT), a leader in the development of innovative therapeutics for the treatment of infectious respiratory diseases, announced today the appointment of Hannah Blau, M.B.B.S,to its scientific advisory board.

Read more

September 17, 2013

Hugh M. O’Brodovich, M.D., Joins AIT’s SAB

Rehovot, Israel – 17 September 2013 – Israeli biomed company AIT (Advanced Inhalation Therapies Ltd.), a leader in the development of nitric oxide therapeutics for the treatment of infectious respiratory diseases, announced today the appointment of Hugh M. O’Brodovich, M.D.,to its scientific advisory board.

Read more

August 21, 2013

AIT Ltd. And Clalit Health Services

AIT Ltd. and Clalit Health Services expand strategic alliance and plan Phase II clinical trial for Respiratory diseases

Read more